In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Showing 21 to 26 of 26

TitleConsultationTypeConsultation end date
Topical tapinarof for treating mild to severe plaque psoriasis ID6712Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Software with artificial intelligence (AI)-derived algorithms to help interpret electroencephalograms (EEGs) for suspected epilepsy: early-use assessmentDraft guidanceHealthTech guidance
Resmetirom for treating non-alcoholic steatohepatitis and liver fibrosis [ID6529]Draft guidanceTechnology appraisal guidance
Teclistamab for treating relapsed or refractory multiple myeloma after 1 or more treatments ID6628Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Mezigdomide with dexamethasone and carfilzomib for treating relapsed or refractory multiple myeloma after at least 1 line of treatment ID6513Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Renal sympathetic denervation for resistant hypertensionDraft scope consultationHealthTech guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All